ESC Premium Access

Evaluation of ABC-stroke and CHA2DS2-VASc ischemic scores in real-world atrial fibrillation patients receiving oral anticoagulation treatment.

Congress Presentation

About the speaker

Doctor Maria Asuncion Esteve Pastor

Virgen de la Arrixaca University Clinical Hospital, Murcia (Spain)
0 follower

5 more presentations in this session

Stroke and cardiovascular outcomes for patients with atrial fibrillation in the community - an opportunity for improvement?

Speaker: Doctor K. Poppe (Auckland, NZ)


Use of multiple biomarkers to improve CHA2DS2-VASc and HAS-BLED scores in the prediction of thromboembolic and bleeding events.

Speaker: Doctor F. Marin (Murcia, ES)


Thoracoscopic left atrial appendectomy can prevent patients with atrial fibrillation from thromboembolism without anticoagulants

Speaker: Doctor T. Inoue (Tokyo, JP)


Predictive value of the CHA2DS2-VASc score for cardiovascular death in comparison with stroke in patients with atrial fibrillation: The Fushimi AF Registry

Speaker: Doctor Y. An (Kyoto, JP)


Performance of the CHA2DS2-VASc score in patients with atrial fibrillation and recent cancer

Speaker: Doctor M. D'Souza (Copenhagen, DK)


Access the full session

Outcomes in atrial fibrillation: room for improvement?

Speakers: Doctor M. Esteve Pastor, Doctor K. Poppe, Doctor F. Marin, Doctor T. Inoue, Doctor Y. An...

About the event


ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb